Natural History of HIV-associated Esophageal Disease in the Era of Protease Inhibitor Therapy

Overview

Journal Dig Dis Sci

Specialty Gastroenterology

Date 2000 Aug 29

PMID 10961707

Citations 3

Authors

E J Bini

P L Micale

E H Weinshel

Affiliations

Soon will be listed here.

Abstract

The aim of this study was to determine the outcome of patients with HIV-associated esophageal disease refractory to empiric antifungal therapy, both before and after the introduction of protease inhibitors. We reviewed the medical records of 629 consecutive HIV-infected patients with odynophagia, dysphagia, or both esophageal symptoms refractory to at least one week of empiric antifungal therapy who underwent endoscopy between January 1992 and January 1997 at Bellevue Hospital Center. Endoscopy identified an etiology in 96.2% of patients, with cytomegalovirus ulcers (40.0%) and idiopathic ulcers of the esophagus (26.67%) being the most common lesions found. Overall, 91.4% of patients had a response to disease-specific therapy. In patients taking protease inhibitors, recurrent symptoms were less common (26.5% vs 36.7%, P = 0.03) and median survival was longer (172 vs 125 weeks. P = 0.006) than in those who were not treated with these potent antiretroviral medications. Protease inhibitors have had a positive impact on the outcome of HIV-associated esophageal disease.

Citing Articles

The spectrum of esophagitis in patients living with HIV - a scoping review.

Olariu M, Olariu M, Iancu A, Sandulescu O, Streinu-Cercel A, Barbu E Germs. 2024; 14(2):188-196.

PMID: 39493738 PMC: 11527493. DOI: 10.18683/germs.2024.1430.

Infectious esophagitis in the immunosuppressed: Candida and beyond.

Zakharia K, Tabibian J J Community Med (Reno). 2020; 1.

PMID: 31897451 PMC: 6939767. DOI: 10.33582/2637-4900/1004.

Infectious Esophagitis.

Mulhall B, Wong R Curr Treat Options Gastroenterol. 2003; 6(1):55-70.

PMID: 12521573 DOI: 10.1007/s11938-003-0034-5.

References

Walsh J, Jones C, Barnes E, Gazzard B, Mitchell S . Increasing survival in AIDS patients with cytomegalovirus retinitis treated with combination antiretroviral therapy including HIV protease inhibitors. AIDS. 1998; 12(6):613-8. DOI: 10.1097/00002030-199806000-00010. View

Wilcox C, Schwartz D, Clark W . Esophageal ulceration in human immunodeficiency virus infection. Causes, response to therapy, and long-term outcome. Ann Intern Med. 1995; 123(2):143-9. DOI: 10.7326/0003-4819-123-2-199507150-00010. View

Parente F, Cernuschi M, Rizzardini G, Lazzarin A, Valsecchi L, Bianchi Porro G . Opportunistic infections of the esophagus not responding to oral systemic antifungals in patients with AIDS: their frequency and treatment. Am J Gastroenterol. 1991; 86(12):1729-34. View

Jacobson M, French M . Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy. AIDS. 1998; 12 Suppl A:S157-63. View

Parente F, Bianchi Porro G . Treatment of cytomegalovirus esophagitis in patients with acquired immune deficiency syndrome: a randomized controlled study of foscarnet versus ganciclovir. The Italian Cytomegalovirus Study Group. Am J Gastroenterol. 1998; 93(3):317-22. DOI: 10.1111/j.1572-0241.1998.00317.x. View

Wilcox C, Schwartz D . Comparison of two corticosteroid regimens for the treatment of HIV-associated idiopathic esophageal ulcer. Am J Gastroenterol. 1994; 89(12):2163-7. View

. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Department of Health and Human Services and the Henry J. Kaiser Family Foundation. Ann Intern Med. 1998; 128(12 Pt 2):1079-100. DOI: 10.7326/0003-4819-128-12_part_2-199806151-00003. View

Dieterich D, Poles M, Dicker M, Tepper R, Lew E . Foscarnet treatment of cytomegalovirus gastrointestinal infections in acquired immunodeficiency syndrome patients who have failed ganciclovir induction. Am J Gastroenterol. 1993; 88(4):542-8. View

Deeks S, Smith M, Holodniy M, Kahn J . HIV-1 protease inhibitors. A review for clinicians. JAMA. 1997; 277(2):145-53. View

10.

Palella Jr F, Delaney K, Moorman A, Loveless M, Fuhrer J, Satten G . Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998; 338(13):853-60. DOI: 10.1056/NEJM199803263381301. View

11.

CARPENTER C, Fischl M, Hammer S, Hirsch M, Jacobsen D, Katzenstein D . Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. JAMA. 1998; 280(1):78-86. DOI: 10.1001/jama.280.1.78. View

12.

Wilcox C, Straub R, Alexander L, Clark W . Etiology of esophageal disease in human immunodeficiency virus-infected patients who fail antifungal therapy. Am J Med. 1996; 101(6):599-604. DOI: 10.1016/s0002-9343(96)00303-8. View

13.

Kotler D, Reka S, Orenstein J, Fox C . Chronic idiopathic esophageal ulceration in the acquired immunodeficiency syndrome. Characterization and treatment with corticosteroids. J Clin Gastroenterol. 1992; 15(4):284-90. DOI: 10.1097/00004836-199212000-00004. View

14.

Bonacini M, Young T, Laine L . The causes of esophageal symptoms in human immunodeficiency virus infection. A prospective study of 110 patients. Arch Intern Med. 1991; 151(8):1567-72. View

15.

Masur H, Whitcup S, Cartwright C, Polis M, Nussenblatt R . Advances in the management of AIDS-related cytomegalovirus retinitis. Ann Intern Med. 1996; 125(2):126-36. DOI: 10.7326/0003-4819-125-2-199607150-00009. View

16.

Rabeneck L, Laine L . Esophageal candidiasis in patients infected with the human immunodeficiency virus. A decision analysis to assess cost-effectiveness of alternative management strategies. Arch Intern Med. 1994; 154(23):2705-10. DOI: 10.1001/archinte.1994.00420230096011. View

17.

Wilcox C, Straub R, Schwartz D . Cytomegalovirus esophagitis in AIDS: a prospective evaluation of clinical response to ganciclovir therapy, relapse rate, and long-term outcome. Am J Med. 1995; 98(2):169-76. DOI: 10.1016/s0002-9343(99)80400-8. View

18.

Nelson M, Connolly G, Hawkins D, Gazzard B . Foscarnet in the treatment of cytomegalovirus infection of the esophagus and colon in patients with the acquired immune deficiency syndrome. Am J Gastroenterol. 1991; 86(7):876-81. View

19.

Wilcox C . Esophageal disease in the acquired immunodeficiency syndrome: etiology, diagnosis, and management. Am J Med. 1992; 92(4):412-21. DOI: 10.1016/0002-9343(92)90272-d. View

20.

Wilcox C, Alexander L, Clark W, Thompson 3rd S . Fluconazole compared with endoscopy for human immunodeficiency virus-infected patients with esophageal symptoms. Gastroenterology. 1996; 110(6):1803-9. DOI: 10.1053/gast.1996.v110.pm8964406. View